Skandinaviska Enskilda Banken (SEB)
BOLD

Skandinaviska Enskilda Banken (SEB)’s Audentes Therapeutics, Inc BOLD Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-109,709
Closed -$6.57M – 973
2019
Q4 		$6.57M Buy
+109,709
New +$4.12M 0.05% 274

Skandinaviska Enskilda Banken (SEB)'s BOLD Position: Q1 2020 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 109,709 shares — an estimated $6.57M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $6.57M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 109,709 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $6.57M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Audentes Therapeutics, Inc position peaked at $6.57M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2020, filed 13 May 2020.